WHO ICTRP trial
A trial in COVID19 patients suffering from severe lung infection to evaluate the…
EUCTR2021-000399-12-BE · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2021-000399-12-BE |
|---|---|
| Public title | A trial in COVID19 patients suffering from severe lung infection to evaluate the safety and effect of infusion with STC3141 |
| Scientific title | A Randomized, Open-Label, Multi-Centre, Phase 2a Study to Evaluate the Safety and Effect of STC3141 Continuous Infusion in Subjects with Severe COVID-19 Pneumonia |
| Primary sponsor | Grand Medical Pty Ltd |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): yes Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): no |
| Countries | Belgium |
| Conditions | severe pneumonia due to COVID-19 MedDRA version: 23.1 Level: PT Classification code 10084380 Term: COVID-19 pneumonia System Organ Class: 10021881 - Infections and infestations ;Therapeutic area: Diseases [C] - Virus Diseases [C02] |
| Interventions | Product Code: STC3141 Pharmaceutical Form: Concentrate for solution for infusion |
| Registration date | Mar 22, 2021 |
| Target size | 25 |
| Secondary IDs | GPHIP_0202 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: